Canine Arthritis Treatment Market Analysis: Understanding The Drivers Behind 4.7% CAGR Through 2030 Growth
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Canine Arthritis Treatment Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The canine arthritis treatment market size has witnessed strong expansion in recent years. It is anticipated to grow from $2.47 billion in 2025 to $2.6 billion in 2026, at a compound annual growth rate (CAGR) of 5.4%. This historical growth can be attributed to the increasing prevalence of canine arthritis, heightened awareness among pet owners, innovations in veterinary pharmaceuticals, an expanding dog population, and the proliferation of veterinary clinics and hospitals.
The canine arthritis treatment market is projected to experience consistent expansion in the coming years, reaching a valuation of $3.13 billion by 2030, driven by a compound annual growth rate (CAGR) of 4.7%. This anticipated growth is attributable to several factors, including the advancement of targeted biologic treatments, the rising integration of precision medicine in veterinary practices, breakthroughs in surgical methods for joint repair, the expansion of online and retail veterinary pharmacy services, and increased funding for stem cell and PRP research. Key trends anticipated during this period encompass the growing acceptance of non-steroidal anti-inflammatory drugs (NSAIDs), a greater reliance on joint supplements such as glucosamine and chondroitin, the expansion of stem cell therapy and platelet-rich plasma (PRP) treatments, an increase in minimally invasive surgical options for canines, and the incorporation of physical therapy and cold laser therapy into arthritis management protocols.
Get A Free Sample Report With In-Depth Market Insights:
Canine Arthritis Treatment Market Growth Factors: What’s Supporting Expansion?
The escalating rate of pet ownership is anticipated to stimulate the advancement of the canine arthritis treatment market in the foreseeable future. Pet ownership encompasses the responsibility and care undertaken by individuals or households in catering to the necessities, well-being, and companionship of domesticated animals kept primarily for pleasure rather than practical purposes. This increase in pet ownership is driven by factors such as shifts in lifestyle, the humanization of pets, and elevated disposable incomes. Pet owners utilize canine arthritis treatments to control and ease the manifestations of arthritis in their dogs, with the goal of enhancing their pets’ quality of life and sustaining their mobility. For example, in April 2025, the Canadian Animal Health Institute, a Canada-based trade association, indicated that in 2024, Canada housed an estimated 7.2 million dogs and 8.2 million cats, demonstrating that pets are a vital component of more than half of Canadian households. Therefore, the growing pet ownership rate is a key factor propelling the expansion of the canine arthritis treatment market.
Canine Arthritis Treatment Market Segments: Where Is Growth Concentrated?
The canine arthritis treatment market covered in this report is segmented –
1) By Treatment Type: Drugs, Supplements, Surgical Procedures, Other Treatment Types
2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations
3) By Arthritis Type: Osteoarthritis, Rheumatoid Arthritis, Osteochondrosis, Traumatic Arthritis
4) By Distribution Channels: Veterinary Clinics And Hospitals, Retail Pharmacies, Online Pharmacies
Subsegments:
1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Osteoarthritis Drugs (DMOADs), Corticosteroids, Analgesics And Pain Relievers
2) By Supplements: Glucosamine And Chondroitin Supplements, Omega-3 Fatty Acids And Fish Oil, Hyaluronic Acid Supplements, MSM (Methylsulfonylmethane) Supplements, Collagen-Based Supplements
3) By Surgical Procedures: Joint Replacement Surgery, Arthroscopy, Osteotomy, Synovectomy
4) By Other Treatment Types: Physical Therapy, Stem Cell Therapy, Platelet-Rich Plasma (PRP) Therapy, Cold Laser Therapy (Low-Level Laser Therapy), Acupuncture
Canine Arthritis Treatment Market Industry Trends: What’s Reshaping Demand?
Leading firms within the canine arthritis treatment market are introducing novel therapies, specifically bedinvetmab injections, aimed at improving canine joint health and overall mobility. Bedinvetmab, a type of monoclonal antibody injection, functions by specifically targeting and deactivating nerve growth factor (NGF), which is a protein linked to pain in veterinary applications. For example, during May 2023, the US-based animal health corporation, Zoetis Inc., obtained approval from the Food and Drug Administration (FDA) for its product Librela, which is a bedinvetmab injection. This product marks the FDA’s initial approval of a monoclonal antibody (mAb) for canine use, operating by binding to and suppressing the biological effects of canine nerve growth factor (NGF), a key component in regulating pain linked to OA. Administered via subcutaneous injection just once a month, it presents a convenient and enduring option for managing osteoarthritic pain in dogs.
Canine Arthritis Treatment Market Key Players Shaping Industry Direction
Major companies operating in the canine arthritis treatment market are Merck & Co. Inc., Bayer AG, Eli Lilly and Company, Zoetis Inc., Boehringer Ingelheim Animal Health, Elanco Animal Health Incorporated, Royal Canin SAS, Virbac Group, Ceva Sante Animale S.A., Hill’s Pet Nutrition Inc., Vetoquinol SA, Norbrook Laboratories Limited, American Regent Inc., Thorne Healthtech Inc., VetStem Inc., Eltech K-Laser s.r.l., Liquid Health Inc, Nutri-Vet LLC, OrthoPets LLC, Rejuvenate Bio Inc.
View The Full Canine Arthritis Treatment Market Report:
Canine Arthritis Treatment Market Regional Analysis: Which Geography Leads On Revenue?
North America was the largest region in the canine arthritis treatment market in 2025. Asia-Pacifica is expected to be the fastest-growing region in the forecast period. The regions covered in the canine arthritis treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
